UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037943
Receipt number R000043250
Scientific Title Neural substrates of body perception for children and adults with ASD
Date of disclosure of the study information 2019/09/10
Last modified on 2019/12/03 07:13:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neural substrates of body perception for children and adults with ASD

Acronym

Neural substrates of body perception for children and adults with ASD

Scientific Title

Neural substrates of body perception for children and adults with ASD

Scientific Title:Acronym

Neural substrates of body perception for children and adults with ASD

Region

Japan


Condition

Condition

Autism spectrum disorder (ASD)

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the neural underpinnings of body perception for individuals with ASD

Basic objectives2

Others

Basic objectives -Others

To compare brain activation between individuals with and without ASD while they observe body parts

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

fMRI

Key secondary outcomes

AQ, SRS, SP, DCDQ, MABC-2


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

adults with ASD

Interventions/Control_2

children with ASD

Interventions/Control_3

healthy adults

Interventions/Control_4

healthy children

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

9 years-old <=

Age-upper limit

49 years-old >=

Gender

Male

Key inclusion criteria

1) Adults who diagnosed with ASD by DSM-5
2) Adults who give informed consent

Key exclusion criteria

1) Adults who have metal thing in the body
2) Adults who have difficulty in audiovisual function
3) Adults who have difficulty in motor function

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hirotaka
Middle name
Last name Kosaka

Organization

University of Fukui

Division name

Department of Neuropsychiatry

Zip code

910-1193

Address

23-3 Matsuokashimoaizuki, Eiheiji, Fukui, Japan

TEL

0776-61-8363

Email

hirotaka@u-fukui.ac.jp


Public contact

Name of contact person

1st name Hirotaka
Middle name
Last name Kosaka

Organization

University of Fukui

Division name

Department of Neuropsychiatry

Zip code

910-1193

Address

23-3 Matsuokashimoaizuki, Eiheiji, Fukui, Japan

TEL

0776-61-8363

Homepage URL


Email

hirotaka@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui

Institute

Department

Personal name



Funding Source

Organization

the Meiji Yasuda Mental Health Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Fukui

Address

23-3 Matsuokashimoaizuki, Eiheiji, Fukui, Japan

Tel

0776-61-3111

Email

bsk-ks@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 09 Month 04 Day

Date of IRB


Anticipated trial start date

2019 Year 10 Month 05 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 05 Day

Last modified on

2019 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043250